Respiration and autonomic regulation and orexin

Progress in Brain Research

Volumn 198, Issue , 2012, Pages 25-46

  Nattie, Eugene ^a   Li, Aihua ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Almorexant; Blood pressure; Chemoreception; Orexin

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; ALMOREXANT; CARBON DIOXIDE; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; OREXIN B; OXYGEN; STRESS HORMONE;

ANALGESIA; AROUSAL; ARTICLE; BLOOD PRESSURE; BREATHING; CEREBROSPINAL FLUID; CHEMORECEPTOR; CHEMOSENSITIVITY; CIRCADIAN RHYTHM; LOCOMOTION; MEAN ARTERIAL PRESSURE; NERVE CELL; NERVE CONDUCTION; NONHUMAN; NONREM SLEEP; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REM SLEEP; STRESS; SYMPATHETIC TONE; THERMOREGULATION; WAKEFULNESS;

EID: 84863883078     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59489-1.00004-5     Document Type: Chapter

References (116)

1. Adamantidis A., de Lecea L. Sleep and metabolism: Shared circuits, new connections. Trends in Endocrinology and Metabolism 2008, 19:362-370.
2. Adamantidis A., de Lecea L. The hypocretins as sensors for metabolism and arousal. The Journal of Physiology 2009, 587:33-40.
3. Antunes V.R., Brailoiu G.C., Kwok E.H., Scruggs P., Dun N.J. Orexins/hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2001, 281:R1801-R1807.
4. Bartlett D.J. Origin and regulation of spontaneous deep breaths. Respiration Physiology 1973, 12:230-238.
5. Bastianini S., Silvani A., Berteotti C., Elghozi J.L., Franzini C., Lenzi P., et al. Sleep related changes in blood pressure in hypocretin-deficient narcoleptic mice. Sleep 2011, 34:213-218.
6. Baumann C.R., Bassetti C.L. Hypocretins (orexins) and sleep-wake disorders. Lancet Neurology 2005, 4:673-682.
7. Boutrel B., Cannella N., de Lecea L. The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Research 2009, 1314:103-111.
8. Brisbare-Roch C., Dingemanse J., Koberstein R., Hoever P., Aissaoui H., Flores S., et al. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nature Medicine 2007, 13:150-155.
9. Busquets X., Barbe F., Barcelo A., de la Pena M., Sigritz N., Mayoralas L.R., et al. Decreased plasma levels of orexin-A in sleep apnea. Respiration; International Review of Thoracic Diseases 2004, 71:575-579.
10. Carter M.E., Adamantidis A., Ohtsu H., Deisseroth K., de Lecea L. Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2009, 29:10939-10949.
11. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., et al. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell 1999, 98:437-451.
12. Chen C.T., Hwang L.L., Chang J.K., Dun N.J. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2000, 278:R692-R697.
13. Chiou L.C., Lee H.J., Ho Y.C., Chen S.P., Liao Y.Y., Ma C.H., et al. Orexins/hypocretins: Pain regulation and cellular actions. Current Pharmaceutical Design 2010, 16:3089-3100.
14. Chokroverty S. Sleep apnea in narcolepsy. Sleep 1986, 9:250-253.
15. Ciriello J., de Oliveira C.V. Cardiac effects of hypocretin-1 in nucleus ambiguus. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2003, 284:R1611-R1620.
16. Ciriello J., Li Z., de Oliveira C.V. Cardioacceleratory responses to hypocretin-1 injections into rostral ventromedial medulla. Brain Research 2003, 991:84-95.
17. Corcoran A., Richerson G., Harris M. Modulation of respiratory activity by hypocretin-1 (orexin A) in situ and in vitro. Advances in Experimental Medicine and Biology 2010, 669:109-113.
18. + dialysis in the caudal ventrolateral medulla (Loeschcke's area) increases ventilation in wakefulness. Respiratory Physiology & Neurobiology 2010, 171:46-53.
19. de Lecea L. A decade of Hypocretins: Past, present and future of the neurobiology of arousal. Acta Physiologica (Oxford, England) 2009, 198:203-208.
20. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., et al. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:322-327.
21. de Oliveira C.V., Ciriello J. Cardiovascular responses to hypocretin-1 in nucleus ambiguus of the ovariectomized female rat. Brain Research 2003, 986:148-156.
22. de Oliveira C.V., Rosas-Arellano M.P., Solano-Flores L.P., Ciriello J. Cardiovascular effects of hypocretin-1 in nucleus of the solitary tract. American Journal of Physiology. Heart and Circulatory Physiology 2003, 284:H1369-H1377.
23. Deng B.S., Nakamura A., Zhang W., Yanagisawa M., Fukuda Y., Kuwaki T. Contribution of orexin in hypercapnic chemoreflex: Evidence from genetic and pharmacological disruption and supplementation studies in mice. Journal of Applied Physiology 2007, 103:1772-1779.
24. Desarnaud F., Murillo-Rodriguez E., Lin L., Xu M., Gerashchenko D., Shiromani S.N., et al. The diurnal rhythm of hypocretin in young and old F344 rats. Sleep 2004, 27:851-856.
25. Dias M.B., Li A., Nattie E.E. Antagonism of orexin receptor-1 in the retrotrapezoid nucleus inhibits the ventilatory response to hypercapnia predominantly in wakefulness. The Journal of Physiology 2009, 587:2059-2067.
26. Dias M.B., Li A., Nattie E. The orexin receptor 1 (OX1R) in the rostral medullary raphe contributes to the hypercapnic chemoreflex in wakefulness, during the active period of the diurnal cycle. Respiratory Physiology & Neurobiology 2010, 170:96-102.
27. Dillon G.H., Waldrop T.G. In vitro responses of caudal hypothalamic neurons to hypoxia and hypercapnia. Neuroscience 1992, 51:941-950.
28. Donadio V., Plazzi G., Vandi S., Franceschini C., Karlsson T., Montagna P., et al. Sympathetic and cardiovascular activity during cataplexy in narcolepsy. Journal of Sleep Research 2008, 17:458-463.
29. Dun N.J., Le Dun S., Chen C.T., Hwang L.L., Kwok E.H., Chang J.K. Orexins: A role in medullary sympathetic outflow. Regulatory Peptides 2000, 96:65-70.
30. Dutschmann M., Kron M., Morschel M., Gestreau C. Activation of Orexin B receptors in the pontine Kolliker-Fuse nucleus modulates pre-inspiratory hypoglossal motor activity in rat. Respiratory Physiology & Neurobiology 2007, 159:232-235.
31. Feldman J.L., Mitchell G.S., Nattie E.E. Breathing: Rhythmicity, plasticity, chemosensitivity. Annual Review of Neuroscience 2003, 26:239-266.
32. Fronczek R., Overeem S., Reijntjes R., Lammers G.J., van Dijk J.G., Pijl H. Increased heart rate variability but normal resting metabolic rate in hypocretin/orexin-deficient human narcolepsy. Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine 2008, 4:248-254.
33. Ganjavi H., Shapiro C.M. Hypocretin/orexin: A molecular link between sleep, energy regulation, and pleasure. The Journal of Neuropsychiatry and Clinical Neurosciences 2007, 19:413-419.
34. Gestreau C., Bevengut M., Dutschmann M. The dual role of the orexin/hypocretin system in modulating wakefulness and respiratory drive. Current Opinion in Pulmonary Medicine 2008, 14:512-518.
35. Han F. Respiratory regulation in narcolepsy. Sleep & breathing = Schlaf & Atmung 2011, 16:241-245.
36. Han F., Mignot E., Wei Y.C., Dong S.X., Li J., Lin L., et al. Ventilatory chemoresponsiveness, narcolepsy-cataplexy and human leukocyte antigen DQB1*0602 status. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 2010, 36:577-583.
37. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001, 30:345-354.
38. Hara J., Yanagisawa M., Sakurai T. Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions. Neuroscience Letters 2005, 380:239-242.
39. Hervieu G.J., Cluderay J.E., Harrison D.C., Roberts J.C., Leslie R.A. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 2001, 103:777-797.
40. Hirota K., Kushikata T., Kudo M., Kudo T., Smart D., Matsuki A. Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle-aged rats. Brain Research 2003, 981:143-150.
41. Hodges M.R., Klum L., Leekley T., Brozoski D.T., Bastasic J., Davis S., et al. Effects on breathing in awake and sleeping goats of focal acidosis in the medullary raphe. Journal of Applied Physiology 2004, 96:1815-1824.
42. Hodges M.R., Martino P., Davis S., Opansky C., Pan L.G., Forster H.V. Effects on breathing of focal acidosis at multiple medullary raphe sites in awake goats. Journal of Applied Physiology 2004, 97:2303-2309.
43. Hodges M.R., Richerson G.B. Medullary serotonin neurons and their roles in central respiratory chemoreception. Respiratory Physiology & Neurobiology 2010, 173:256-263.
44. 2 chemoreception, and thermoregulation. Journal of Applied Physiology 2010, 108:1425-1432.
45. Huang S.C., Dai Y.W., Lee Y.H., Chiou L.C., Hwang L.L. Orexins depolarize rostral ventrolateral medulla neurons and increase arterial pressure and heart rate in rats mainly via orexin 2 receptors. The Journal of Pharmacology and Experimental Therapeutics 2010, 334:522-529.
46. Jochem J., Zwirska-Korczala K., Zabielski R., Kato I., Kuwahara A. Cardiovascular effects of centrally acting orexin A in haemorrhage-shocked rats. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 2006, 57(Suppl. 11):115-124.
47. Johnson P.L., Truitt W., Fitz S.D., Minick P.E., Dietrich A., Sanghani S., et al. A key role for orexin in panic anxiety. Nature Medicine 2010, 16:111-115.
48. Jones B.E. From waking to sleeping: Neuronal and chemical substrates. Trends in Pharmacological Sciences 2005, 26:578-586.
49. Kannan H., Shirasaka T., Watanabe S., Yu N.S., Kuitake T., Takasaki M. Central action of orexins on sympathetic outflow and cardiovascular function with a focus on the paraventricular nucleus of the hypothalamus. Masui. The Japanese Journal of Anesthesiology 2007, 56:30-39.
50. Kayaba Y., Nakamura A., Kasuya Y., Ohuchi T., Yanagisawa M., Komuro I., et al. Attenuated defense response and low basal blood pressure in orexin knockout mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2003, 285:R581-R593.
51. Kinney H.C., Richerson G.B., Dymecki S.M., Darnall R.A., Nattie E.E. The brainstem and serotonin in the sudden infant death syndrome. Annual Review of Pathology 2009, 4:517-550.
52. Kinney H.C., Thach B.T. The sudden infant death syndrome. The New England Journal of Medicine 2009, 361:795-805.
53. Kuwaki T. Orexinergic modulation of breathing across vigilance states. Respiratory Physiology & Neurobiology 2008, 164:204-212.
54. Kuwaki T. Hypothalamic modulation of breathing. Advances in Experimental Medicine and Biology 2010, 669:243-247.
55. Kuwaki T. Orexin links emotional stress to autonomic functions. Autonomic Neuroscience: Basic & Clinical 2011, 161:20-27.
56. Kuwaki T., Li A., Nattie E. State-dependent central chemoreception: A role of orexin. Respiratory Physiology & Neurobiology 2010, 173:223-229.
57. Kuwaki T., Zhang W., Nakamura A., Deng B.S. Emotional and state-dependent modification of cardiorespiratory function: Role of orexinergic neurons. Autonomic Neuroscience: Basic & Clinical 2008, 142:11-16.
58. Lazarenko R.M., Stornetta R.L., Bayliss D.A., Guyenet P.G. Orexin A activates retrotrapezoid neurons in mice. Respiratory Physiology & Neurobiology 2011, 175:283-287.
59. Lee M.G., Hassani O.K., Jones B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2005, 25:6716-6720.
60. 2 dialysis in one chemoreceptor site, the RTN: Stimulus intensity and sensitivity in the awake rat. Respiratory Physiology & Neurobiology 2002, 133:11-22.
61. Li A., Nattie E. Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle. The Journal of Physiology 2010, 588:2935-2944.
62. Li A., Randall M., Nattie E.E. CO(2) microdialysis in retrotrapezoid nucleus of the rat increases breathing in wakefulness but not in sleep. Journal of Applied Physiology 1999, 87:910-919.
63. 2 response in conscious rats. The Journal of Physiology 2006, 577:307-318.
64. Liewellyn-Smith I.J., Martin C.L., Marcus J.N., Yanagisawa M., Minson J.B., Scammell T.E. Orexin-immunoreactive inputs to rat sympathetic preganglionic neurons. Neuroscience Letters 2003, 351:115-119.
65. Lin Y., Matsumura K., Tsuchihashi T., Abe I., Iida M. Chronic central infusion of orexin-A increases arterial pressure in rats. Brain Research Bulletin 2002, 57:619-622.
66. Machado B.H., Bonagamba L.G., Dun S.L., Kwok E.H., Dun N.J. Pressor response to microinjection of orexin/hypocretin into rostral ventrolateral medulla of awake rats. Regulatory Peptides 2002, 104:75-81.
67. Mahamed S., Mitchell G.S. Respiratory long-term facilitation: Too much or too little of a good thing?. Advances in Experimental Medicine and Biology 2008, 605:224-227.
68. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., et al. Differential expression of orexin receptors 1 and 2 in the rat brain. The Journal of Comparative Neurology 2001, 435:6-25.
69. Martins P.J., D'Almeida V., Pedrazzoli M., Lin L., Mignot E., Tufik S. Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity. Regulatory Peptides 2004, 117:155-158.
70. Matsumura K., Tsuchihashi T., Abe I. Central orexin-A augments sympathoadrenal outflow in conscious rabbits. Hypertension 2001, 37:1382-1387.
71. Matsumura K., Tsuchihashi T., Fujii K., Iida M. Neural regulation of blood pressure by leptin and the related peptides. Regulatory Peptides 2003, 114:79-86.
72. McGuire M., Zhang Y., White D.P., Ling L. Effect of hypoxic episode number and severity on ventilatory long-term facilitation in awake rats. Journal of Applied Physiology 2002, 93:2155-2161.
73. Mileykovskiy B.Y., Kiyashchenko L.I., Siegel J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005, 46:787-798.
74. Mochizuki T., Klerman E.B., Sakurai T., Scammell T.E. Elevated body temperature during sleep in orexin knockout mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2006, 291:R533-R540.
75. Nakamura A., Olson E.B., Terada J., Wenninger J.M., Bisgard G.E., Mitchell G.S. Sleep state dependence of ventilatory long-term facilitation following acute intermittent hypoxia in Lewis rats. Journal of Applied Physiology 2010, 109:323-331.
76. Nakamura A., Zhang W., Yanagisawa M., Fukuda Y., Kuwaki T. Vigilance state-dependent attenuation of hypercapnic chemoreflex and exaggerated sleep apnea in orexin knockout mice. Journal of Applied Physiology 2007, 102:241-248.
77. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Research 1999, 827:243-260.
78. Nattie E., Comroe Julius H. distinguished lecture: Central chemoreception: Then ... and now. Journal of Applied Physiology 2011, 110:1-8.
79. Nattie E., Li A. Central chemoreception is a complex system function that involves multiple brain stem sites. Journal of Applied Physiology 2009, 106:1464-1466.
80. Nattie E., Li A. Central chemoreception in wakefulness and sleep: Evidence for a distributed network and a role for orexin. Journal of Applied Physiology 2010, 108:1417-1424.
81. Nixon J.P., Smale L. A comparative analysis of the distribution of immunoreactive orexin A and B in the brains of nocturnal and diurnal rodents. Behavioral and Brain Functions 2007, 3:28.
82. Olson E.B., Bohne C.J., Dwinell M.R., Podolsky A., Vidruk E.H., Fuller D.D., et al. Ventilatory long-term facilitation in unanesthetized rats. Journal of Applied Physiology 2001, 91:709-716.
83. Parekh B. The mechanism of dead-in-bed syndrome and other sudden unexplained nocturnal deaths. Current Diabetes Reviews 2009, 5:210-215.
84. Parekh B. Mechanisms of the blunting of the sympatho-adrenal response: A theory. Current Diabetes Reviews 2009, 5:79-91.
85. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature Medicine 2000, 6:991-997.
86. Plazzi G., Moghadam K.K., Maggi L.S., Donadio V., Vetrugno R., Liguori R., et al. Autonomic disturbances in narcolepsy. Sleep Medicine Reviews 2011, 15:187-196.
87. Ptak K., Yamanishi T., Aungst J., Milescu L.S., Zhang R., Richerson G.B., et al. Raphe neurons stimulate respiratory circuit activity by multiple mechanisms via endogenously released serotonin and substance P. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2009, 29:3720-3737.
88. Ray R.S., Corcoran A.E., Brust R.D., Kim J.C., Richerson G.B., Nattie E., et al. Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition. Science 2011, 333:637-642.
89. Richerson G.B. Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis. Nature Reviews. Neuroscience 2004, 5:449-461.
90. Roecker A.J., Coleman P.J. Orexin receptor antagonists: Medicinal chemistry and therapeutic potential. Current Topics in Medicinal Chemistry 2008, 8:977-987.
91. Rusyniak D.E., Zaretsky D.V., Zaretskaia M.V., Dimicco J.A. The role of orexin-1 receptors in physiologic responses evoked by microinjection of PgE2 or muscimol into the medial preoptic area. Neuroscience Letters 2011, 498:162-166.
92. Sakurai T. Roles of orexins in regulation of feeding and wakefulness. Neuroreport 2002, 13:987-995.
93. Sakurai T. Orexin: A link between energy homeostasis and adaptive behaviour. Current Opinion in Clinical Nutrition and Metabolic Care 2003, 6:353-360.
94. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
95. Samson W.K., Gosnell B., Chang J.K., Resch Z.T., Murphy T.C. Cardiovascular regulatory actions of the hypocretins in brain. Brain Research 1999, 831:248-253.
96. Schwimmer H., Stauss H.M., Abboud F., Nishino S., Mignot E., Zeitzer J.M. Effects of sleep on the cardiovascular and thermoregulatory systems: A possible role for hypocretins. Journal of Applied Physiology 2010, 109:1053-1063.
97. Shahid I.Z., Rahman A.A., Pilowsky P.M. Intrathecal orexin A increases sympathetic outflow and respiratory drive, enhances baroreflex sensitivity and blocks the somato-sympathetic reflex. British Journal of Pharmacology 2011, 162:961-973.
98. Shirasaka T., Nakazato M., Matsukura S., Takasaki M., Kannan H. Sympathetic and cardiovascular actions of orexins in conscious rats. The American Journal of Physiology 1999, 277:R1780-R1785.
99. Shirasaka T., Takasaki M., Kannan H. Cardiovascular effects of leptin and orexins. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2003, 284:R639-R651.
100. Smith P.M., Connolly B.C., Ferguson A.V. Microinjection of orexin into the rat nucleus tractus solitarius causes increases in blood pressure. Brain Research 2002, 950:261-267.
101. Smith P.M., Samson W.K., Ferguson A.V. Cardiovascular actions of orexin-A in the rat subfornical organ. Journal of Neuroendocrinology 2007, 19:7-13.
102. Solomon I.C., Edelman N.H., O'Neal M.H. CO(2)/H(+) chemoreception in the cat pre-Botzinger complex in vivo. Journal of Applied Physiology 2000, 88:1996-2007.
103. Terada J., Mitchell G.S. Diaphragm long-term facilitation following acute intermittent hypoxia during wakefulness and sleep. Journal of Applied Physiology 2011, 110:1299-1310.
104. Terada J., Nakamura A., Zhang W., Yanagisawa M., Kuriyama T., Fukuda Y., et al. Ventilatory long-term facilitation in mice can be observed during both sleep and wake periods and depends on orexin. Journal of Applied Physiology 2008, 104:499-507.
105. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000, 27:469-474.
106. Toyama S., Sakurai T., Tatsumi K., Kuwaki T. Attenuated phrenic long-term facilitation in orexin neuron-ablated mice. Respiratory Physiology & Neurobiology 2009, 168:295-302.
107. Tsujino N., Sakurai T. Orexin/Hypocretin: A neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacological Reviews 2009, 61:162-176.
108. Tupone D., Madden C.J., Cano G., Morrison S.F. An orexinergic projection from perifornical hypothalamus to raphe pallidus increases rat brown adipose tissue thermogenesis. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2011, 31:15944-15955.
109. Williams R.H., Burdakov D. Hypothalamic orexins/hypocretins as regulators of breathing. Expert Reviews in Molecular Medicine 2008, 10:e28.
110. 2 . Proceedings of the National Academy of Sciences of the United States of America 2007, 104:10685-10690.
111. Yamamoto Y., Ueta Y., Hara Y., Serino R., Nomura M., Shibuya I., et al. Postnatal development of orexin/hypocretin in rats. Brain Research. Molecular Brain Research 2000, 78:108-119.
112. Young J.K., Wu M., Manaye K.F., Kc P., Allard J.S., Mack S.O., et al. Orexin stimulates breathing via medullary and spinal pathways. Journal of Applied Physiology 2005, 98:1387-1395.
113. Zhang W., Fukuda Y., Kuwaki T. Respiratory and cardiovascular actions of orexin-A in mice. Neuroscience Letters 2005, 385:131-136.
114. Zhang W., Sakurai T., Fukuda Y., Kuwaki T. Orexin neuron-mediated skeletal muscle vasodilation and shift of baroreflex during defense response in mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2006, 290:R1654-R1663.
115. Zhang W., Shimoyama M., Fukuda Y., Kuwaki T. Multiple components of the defense response depend on orexin: Evidence from orexin knockout mice and orexin neuron-ablated mice. Autonomic Neuroscience: Basic & Clinical 2006, 126-127:139-145.
116. Zhang W., Zhang N., Sakurai T., Kuwaki T. Orexin neurons in the hypothalamus mediate cardiorespiratory responses induced by disinhibition of the amygdala and bed nucleus of the stria terminalis. Brain Research 2009, 1262:25-37.